Literature DB >> 2016601

Correlation between HBV DNA detection by polymerase chain reaction and Pre-S1 antigenemia in symptomatic and asymptomatic hepatitis B virus infections.

I Chemin1, I Baginski, M A Petit, F Zoulim, C Pichoud, F Capel, O Hantz, C Trepo.   

Abstract

The presence of hepatitis B virus (HBV) genome in sera from 73 symptomatic and asymptomatic HBsAg carriers was studied by the polymerase chain reaction (PCR) with primers specific for the S and C regions. Pre-S proteins of the HBV envelope were detected in serum by a specific monoclonal antibody in a double immunoradiometric assay. Out of twenty-five symptomatic patients with chronic active hepatitis (14 with HBeAg and 11 with anti-HBe), all were positive for HBV DNA by PCR, while 14/14 HBeAg and 2/11 (18%) of the anti-HBe patients were positive by dot blot hybridization. All but one anti-HBe patient (96%) carried Pre-S1 proteins. Among the asymptomatic HBsAg carriers, HBV DNA was detected by PCR in 14/14 (100%) HBeAg positive patients and in 25/34 (73%) anti-HBe positive patients. Pre-S1 proteins were found, respectively, in 14/14 (100%) and 11/22 (50%) of the same cases tested in parallel. The 20 healthy blood donors devoid of HBV markers and with normal transaminases tested were found negative for HBV DNA using PCR. Out of 12 patients who recovered from acute hepatitis B, all were found negative by PCR analysis after a mean follow up of 1 year after seroconversion to anti-HBs. When serial samples from 2 patients (one with acute hepatitis B, the other with chronic hepatitis B) were tested for the presence of HBV DNA and of Pre-S1 proteins, both markers showed parallel development.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2016601     DOI: 10.1002/jmv.1890330111

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  7 in total

1.  New assays for quantitative determination of viral markers in management of chronic hepatitis B virus infection.

Authors:  F Zoulim; L Mimms; M Floreani; C Pichoud; I Chemin; A Kay; L Vitvitski; C Trepo
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

2.  Hepatitis B virus X protein identifies the Smc5/6 complex as a host restriction factor.

Authors:  Adrien Decorsière; Henrik Mueller; Pieter C van Breugel; Fabien Abdul; Laetitia Gerossier; Rudolf K Beran; Christine M Livingston; Congrong Niu; Simon P Fletcher; Olivier Hantz; Michel Strubin
Journal:  Nature       Date:  2016-03-17       Impact factor: 49.962

3.  Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only. Swiss HIV Cohort Study.

Authors:  M Hofer; H I Joller-Jemelka; P J Grob; R Lüthy; M Opravil
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-01       Impact factor: 3.267

Review 4.  Polymerase chain reaction for the diagnosis of viral hepatitis B and C.

Authors:  C Bréchot
Journal:  Gut       Date:  1993       Impact factor: 23.059

5.  Duck hepatitis B virus infection, aflatoxin B1 and liver cancer in domestic Chinese ducks.

Authors:  L Cova; R Mehrotra; C P Wild; S Chutimataewin; S F Cao; A Duflot; M Prave; S Z Yu; R Montesano; C Trepo
Journal:  Br J Cancer       Date:  1994-01       Impact factor: 7.640

6.  Frequent reactivations of anti-HBe-positive chronic hepatitis B in patients with no demonstrable HBV DNA in serum by polymerase chain reaction.

Authors:  H S Lee; J H Yoon; C Y Kim
Journal:  Korean J Intern Med       Date:  1995-07       Impact factor: 2.884

7.  Prevalence of the precore G1896A mutation in Chinese patients with e antigen negative hepatitis B virus infection and its relationship to pre-S1 antigen.

Authors:  Jing Zhang; Wei-Jia Xu; Qing Wang; Yong Zhang; Ming Shi
Journal:  Braz J Microbiol       Date:  2009-12-01       Impact factor: 2.476

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.